A clinical double-blind randomized controlled trial about prognosis of atorvastatin treatment of spontaneous subarachnoid hemorrhage

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-14005395

Enrollment

Unknown

Registered

2014-05-18

Start date

2014-10-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spontaneous subarachnoid hemorrhage

Interventions

treatment group:atorvastatin treatment

Eligibility

Sex/Gender

All

Age

20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Clear diagnosis of spontaneous subarachnoid hemorrhage, Gender randomly,age for 20-80 years; 2. For the first time attack, Delivery time within 72 hours.

Exclusion criteria

Exclusion criteria: 1. Traumatic subarachnoid hemorrhage; 2. High cholesterol combined with diabetes; 3. Long-term use of atorvastatin as treatment group; 4. Abnormal liver enzymes, Patients with rhabdomyolysis and myopathy; 5. patients Has a history of mental illness and epilepsy; 6. Patients with severe lung disease and multiple organ dysfunction; and 7. Researchers think Other reasons are not suitable for clinical subjects and patients who participate in other clinical trials of patients.

Design outcomes

Primary

Measure	Time frame
GOS score;vasospasm;Cerebral infarction;	—

Contacts

Public ContactYuhai WANG

wangyuhai67@126.com+86 13771166231

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 2, 2026